IndraLab
Statements
Hydroxychloroquine decreases the amount of IL6. 28 / 28
|
28
reach
"In another single-arm study, administration of hydroxychloroquine to HIV infected persons who experienced suboptimal CD4 T-cell gains after highly active antiretroviral therapy (HAART) resulted in decreased levels of T-cell activation and decreased levels of inflammatory cytokines IL-6 and TNF in plasma."
reach
"This notion, in fact, was partially endorsed by the new results from a multicenter, randomized, double-blind, placebo-controlled OXI pilot trial among 125 patients with MI in Finland, which indicated that early administration of HCQ within 48 h after MI (300 mg once daily for 6 months) significantly reduced serum levels of interleukin-6 (IL-6), a key pro-inflammatory marker and did not cause any significant adverse events [133]."
reach
"This hypothesis, however, remains to be investigated, especially because the humoral response alone may not be sufficient to clear the infection.Considering the effect of drug treatment, hydroxychloroquine (HCQ), known for its anti-inflammatory properties, significantly reduced IL-6 levels, an effect already observed in patients affected by systemic lupus erythematosus (SLE), a chronic autoimmune disease [35, 36]."
reach
"In some trials, adding CQ/HCQ to cART reduced immune activation markers on CD8+ T cells or levels of activated CD4+/Ki67+ and CD14+/CD69+ T cells [113], whereas HCQ did not reduce CD8+ T-cell activation and IL-6/D-dimer levels in other trials, with an increase of viral replication and a decline in CD4+ T cell count [114,115]."
reach
"Among the 51 patients enrolled in the study, HCQ treatment led to significantly reduced serum levels of TNF-alpha, IL-6, IL-8, VEGF-A, IL-1ra, and IL-2 (p < 0.0001; p = 0.0006; p = 0.0460, p = 0.0177; p < 0.0001; p = 0.0282, respectively) and to decreased (but not significantly) levels of MIP-1alpha (p = 0.0746)."